ELAN.US Elanco Animal Health

Healthcare Pharmaceuticals USA Stocks
26.78 USD
Close of Nov 13, 2026
19.40 27.98
Market cap
USD 13.4B
P/E
-
P/B
2.00x
ROE
2.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ELAN.US undervalued?

Graham number

The Graham number of Elanco Animal Health cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Elanco Animal Health fundamental analysis

No fundamental analysis for Elanco Animal Health yet.

Elanco Animal Health stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of f…

Full company profile